0K5R3ZZ
Destruction Upper Leg Muscle, Left to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | K Muscles |
| Operation | 5 Destruction |
| Body Part | R Upper Leg Muscle, Left |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures on the muscles eliminate abnormal or unwanted tissue in place, using heat, cold, chemicals, or another destructive agent, rather than physically cutting the tissue out of the body. In muscle, this is applied less often than in skin or soft tissue, but it shows up in cases like ablation of an abnormal muscle lesion or destruction of a portion of muscle causing chronic pain or spasm.
The tissue is killed and left in the body, where it is absorbed or scarred over time rather than removed as a specimen. This makes Destruction useful when the target tissue is diffuse, hard to access surgically, or when the goal is functional, such as reducing muscle activity, rather than obtaining tissue for diagnosis.
Because nothing is sent to pathology in a pure destruction procedure, these cases are typically planned based on imaging or prior biopsy findings rather than intraoperative tissue analysis.
Anatomy & Axis Detail
Upper Leg Muscle, Left
The left upper leg muscle group, comprising the quadriceps, hamstrings, and adductors, mirrors its right-sided counterpart in bulk and function but is coded separately because laterality changes the ICD-10-PCS body part value. Destruction targets abnormal tissue in place, such as an arteriovenous malformation, calcified myositis ossificans, or a localized infected pocket, through techniques like cryoablation, radiofrequency, laser energy, or injected chemical agents such as botulinum toxin or phenol used to manage spastic contracture. The proximity of the femoral neurovascular bundle and sciatic nerve makes precise targeting important, often guided by ultrasound, CT, or fluoroscopy. Coders should confirm laterality carefully and record the destructive modality used, since destruction differs fundamentally from resection or repair of the same muscle group.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Documentation needs to specify the method of destruction, such as cryoablation, laser, radiofrequency, or a chemical agent, along with the specific muscle or muscle group treated, since the body part character narrows to a fairly granular level of anatomy.
A frequent error is assigning Destruction when tissue was actually removed and sent to pathology, which points instead to Excision. Coders should also watch for procedures that destroy tissue as an incidental part of achieving hemostasis or another goal; if destruction was not the intended objective, it is not the correct root operation.